Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / May / Implement – and Walk Away
Histology Histology Genetics and epigenetics Software and hardware Technology and innovation Insights

Implement – and Walk Away

Automating RNA ISH to build a robust, accurate picture of molecular pathways

05/11/2021 Longer Read (pre 2022) 1 min read

Share

Leica Biosystems has partnered with ACD to create a fully automated, walkaway solution. How? By automating RNA detection and enabling chromogenic ISH (CISH) on the BOND-III fully automated IHC/ISH stainer. BOND RNAscope® Brown Detection is intended for staining sections of FFPE tissue on the BOND-III stainer. 

The ease of adoption of RNA ISH technology on the BOND-III stainer has enabled laboratories to quickly establish this technology, minimizing inter-user variation and optimizing sample pretreatment.

“We introduced BOND-III in our Pathology Department in 2016 for IHC and FISH analysis,” says Denise Morotti, Molecular Geneticist at ASST Papa Giovanni XXIII in Bergamo, Italy. “From the beginning, we had good results, despite our technical staff’s rotating weekly to different laboratory sectors. Thanks to the instrument’s easy setup and intuitive programming, we quickly obtained reproducible staining in a standardized and fully traceable way.”

She continues, “Last spring our hospital was the first in Europe to face the COVID-19 pandemic. We started using BOND-III to look for virus in autopsy samples with a default pretreatment protocol. Within few days, we were able to set up different protocols for a number of tissue specimens – lung, kidney, heart, and placenta. In a couple of weeks, we had collected enough data to better describe and understand what was going on.”

Padua University in Padua, Italy, introduced the fully automated RNAscope Brown Detection kit on BOND-III in the summer of 2020. “By introducing the automated method, we have improved workflow productivity and produced clear staining in a standardized and repeatable way,” says Matteo Fassan, Professor of Pathology.

The BOND RNAscope Brown Detection kit’s ease of adoption has allowed laboratories to effortlessly introduce this new technology into their workflows. Using BOND RNAscope Detection in combination with the BOND-III fully automated IHC/ISH stainer reduces the possibility of human error and the inherent variability that results from repeated reagent dilution, pipetting, and application.


Performance claims for compatible probes have not been established. Probes used in conjunction with BOND RNAscope® Brown Detection should be validated by the user in accordance with local laws and regulations.

www.leicabiosystems.com 

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Your Newest Colleague?
Histology
Your Newest Colleague?

January 6, 2022

1 min read

The need for AI-based end-to-end biomarkers in oncology

Biospecimen Access For Biotechs
Histology
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Case of the Month
Histology
Case of the Month

February 21, 2022

1 min read

The Art of the Laboratory
Histology
The Art of the Laboratory

March 25, 2022

1 min read

For the seventh time, we asked you to share the images you think capture the most beautiful, educational, or amusing aspects of pathology – and you delivered. Welcome to our gallery tour of the most visually striking discipline in medicine!

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.